LINC01014
gene geneOn this page
Summary
LINC01014 (long intergenic non-protein coding RNA 1014, HGNC:41353) is a long non-coding RNA gene on chromosome 3q26.32.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41353 |
| Approved symbol | LINC01014 |
| Name | long intergenic non-protein coding RNA 1014 |
| Location | 3q26.32 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000223941 |
| Ensembl biotype | lncRNA |
| Entrez | 100874330 |
| RNAcentral | URS000007FFF1 — lncRNA, 548 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 lncRNA
ENST00000436432, ENST00000441018, ENST00000455307
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000436432 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001624610 | 178419234 | 178419375 |
| ENSE00001703362 | 178456614 | 178456774 |
| ENSE00001769302 | 178457068 | 178457309 |
Expression profiles
Bgee: expression breadth broad, 89 present calls, max score 82.62.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5393 / max 300.2554, expressed in 64 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 39905 | 0.4576 | 60 |
| 39904 | 0.0817 | 23 |
Top tissues by expression
89 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| islet of Langerhans | UBERON:0000006 | 82.62 | gold quality |
| right uterine tube | UBERON:0001302 | 79.44 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.19 | silver quality |
| fallopian tube | UBERON:0003889 | 70.50 | gold quality |
| pancreas | UBERON:0001264 | 67.29 | gold quality |
| endocervix | UBERON:0000458 | 65.78 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 65.52 | gold quality |
| kidney | UBERON:0002113 | 65.21 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 65.08 | gold quality |
| adenohypophysis | UBERON:0002196 | 61.16 | gold quality |
| cortex of kidney | UBERON:0001225 | 59.48 | gold quality |
| pituitary gland | UBERON:0000007 | 59.20 | gold quality |
| gall bladder | UBERON:0002110 | 58.65 | gold quality |
| corpus callosum | UBERON:0002336 | 58.06 | gold quality |
| endometrium | UBERON:0001295 | 57.80 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 57.37 | gold quality |
| prefrontal cortex | UBERON:0000451 | 57.23 | gold quality |
| body of pancreas | UBERON:0001150 | 57.07 | gold quality |
| blood | UBERON:0000178 | 56.49 | gold quality |
| stromal cell of endometrium | CL:0002255 | 54.53 | silver quality |
| liver | UBERON:0002107 | 54.30 | gold quality |
| caudate nucleus | UBERON:0001873 | 53.86 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 53.69 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 53.29 | gold quality |
| gastrocnemius | UBERON:0001388 | 52.09 | gold quality |
| multicellular organism | UBERON:0000468 | 51.74 | gold quality |
| brain | UBERON:0000955 | 51.41 | gold quality |
| right lobe of liver | UBERON:0001114 | 51.32 | gold quality |
| lung | UBERON:0002048 | 50.91 | gold quality |
| rectum | UBERON:0001052 | 50.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.85 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Linc01014 regulates gefitinib resistance in oesophagus cancer via EGFR-PI3K-AKT-mTOR signalling pathway. (PMID:31785047)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.